PIVLAZ Trademark

Trademark Overview

On Wednesday, October 7, 2020, a trademark application was filed for PIVLAZ with the United States Patent and Trademark Office. The USPTO has given the PIVLAZ trademark a serial number of 79299721. The federal status of this trademark filing is REGISTERED as of Tuesday, January 11, 2022. This trademark is owned by Idorsia Pharmaceuticals Ltd. The PIVLAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of cerebral hemorrhages and their sequelae
pivlaz

General Information

Serial Number79299721
Word MarkPIVLAZ
Filing DateWednesday, October 7, 2020
Status700 - REGISTERED
Status DateTuesday, January 11, 2022
Registration Number6610191
Registration DateTuesday, January 11, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Description of MarkThe mark consists of three wavy lines forming the general shape of a rhombus to the left of the wording "PIVLAZ".
Goods and ServicesPharmaceutical preparations for treatment of cerebral hemorrhages and their sequelae

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIdorsia Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameIdorsia Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameIdorsia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, July 12, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 23, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 23, 2022FINAL DISPOSITION PROCESSED
Monday, April 11, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 11, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 17, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 17, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 5, 2021REFUSAL PROCESSED BY IB
Thursday, March 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 18, 2021REFUSAL PROCESSED BY MPU
Tuesday, March 16, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 15, 2021NON-FINAL ACTION WRITTEN
Monday, March 8, 2021ASSIGNED TO EXAMINER
Thursday, March 4, 2021CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sunday, February 28, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, December 18, 2020APPLICATION FILING RECEIPT MAILED
Monday, December 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 10, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pivlaz their sequelae hemorrhages cerebral preparations treatment pharmaceutical